Exploring the binding efficacy of ivermectin against the key proteins of SARS-CoV-2 pathogenesis: an in silico approach
Aim: COVID-19 is currently the biggest threat to mankind. Recently, ivermectin (a US FDA-
approved antiparasitic drug) has been explored as an anti-SARS-CoV-2 agent. Herein, we …
approved antiparasitic drug) has been explored as an anti-SARS-CoV-2 agent. Herein, we …
[PDF][PDF] Exploring the binding efficacy of ivermectin against the key proteins of SARS-CoV-2 pathogenesis: an in silico approach
A Choudhury, NC Das, R Patra, M Bhattacharya… - 2021 - academia.edu
Aim: COVID-19 is currently the biggest threat to mankind. Recently, ivermectin (a US FDA-
approved antiparasitic drug) has been explored as an anti-SARS-CoV-2 agent. Herein, we …
approved antiparasitic drug) has been explored as an anti-SARS-CoV-2 agent. Herein, we …
[PDF][PDF] Exploring the binding efficacy of ivermectin against the key proteins of SARS-CoV-2 pathogenesis: an in silico approach
A Choudhury, NC Das, R Patra, M Bhattacharya… - 2021 - mymedicalfreedom.org
Aim: COVID-19 is currently the biggest threat to mankind. Recently, ivermectin (a US FDA-
approved antiparasitic drug) has been explored as an anti-SARS-CoV-2 agent. Herein, we …
approved antiparasitic drug) has been explored as an anti-SARS-CoV-2 agent. Herein, we …
[PDF][PDF] Exploring the binding efficacy of ivermectin against the key proteins of SARS-CoV-2 pathogenesis: an in silico approach
A Choudhury, NC Das, R Patra, M Bhattacharya… - 2021 - pdfs.semanticscholar.org
Aim: COVID-19 is currently the biggest threat to mankind. Recently, ivermectin (a US FDA-
approved antiparasitic drug) has been explored as an anti-SARS-CoV-2 agent. Herein, we …
approved antiparasitic drug) has been explored as an anti-SARS-CoV-2 agent. Herein, we …
Exploring the binding efficacy of ivermectin against the key proteins of SARS-CoV-2 pathogenesis: an in silico approach
A Choudhury, N Das, R Patra, M Bhattacharya… - Future …, 2021 - europepmc.org
Aim: COVID-19 is currently the biggest threat to mankind. Recently, ivermectin (a US FDA-
approved antiparasitic drug) has been explored as an anti-SARS-CoV-2 agent. Herein, we …
approved antiparasitic drug) has been explored as an anti-SARS-CoV-2 agent. Herein, we …
[PDF][PDF] Exploring the binding efficacy of ivermectin against the key proteins of SARS-CoV-2 pathogenesis: an in silico approach
A Choudhury, NC Das, R Patra, M Bhattacharya… - 2021 - vlierbloesem.wordpress.com
Aim: COVID-19 is currently the biggest threat to mankind. Recently, ivermectin (a US FDA-
approved antiparasitic drug) has been explored as an anti-SARS-CoV-2 agent. Herein, we …
approved antiparasitic drug) has been explored as an anti-SARS-CoV-2 agent. Herein, we …
[HTML][HTML] Exploring the binding efficacy of ivermectin against the key proteins of SARS-CoV-2 pathogenesis: an in silico approach
A Choudhury, NC Das, R Patra, M Bhattacharya… - Future …, 2021 - ncbi.nlm.nih.gov
Aim: COVID-19 is currently the biggest threat to mankind. Recently, ivermectin (a US FDA-
approved antiparasitic drug) has been explored as an anti-SARS-CoV-2 agent. Herein, we …
approved antiparasitic drug) has been explored as an anti-SARS-CoV-2 agent. Herein, we …
[PDF][PDF] Exploring the binding efficacy of ivermectin against the key proteins of SARS-CoV-2 pathogenesis: an in silico approach
A Choudhury, NC Das, R Patra, M Bhattacharya… - 2021 - mymedicalfreedom.org
Aim: COVID-19 is currently the biggest threat to mankind. Recently, ivermectin (a US FDA-
approved antiparasitic drug) has been explored as an anti-SARS-CoV-2 agent. Herein, we …
approved antiparasitic drug) has been explored as an anti-SARS-CoV-2 agent. Herein, we …